Skip to main content
. Author manuscript; available in PMC: 2020 Mar 19.
Published in final edited form as: J Am Coll Cardiol. 2019 Mar 19;73(10):1173–1184. doi: 10.1016/j.jacc.2018.12.053

Figure 7. PDE3 inhibitor treatment results in increased PLN in PDE3 inhibitor-treated DEL carriers.

Figure 7.

PLN mRNA abundance is increased in treated DEL/INS and DEL carriers when compared to untreated patients. mRNA levels were normalized to 18S and relative normalization is to all non-failings. ANOVA/Newman-Keuls test significance is shown in the Figure (* in comparison to untreated). N.S. – not significant.